Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon V Tiu

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Expert Opinion on Investigational Drugs|June 7, 2012
Immunomodulatory agents in myelofibrosisAli Tabarroki, Ramon V Tiu
Therapeutic Advances in Hematology|November 1, 2014
Practical management of patients with chronic myeloid leukemia who develop tyrosine kinase inhibitor-resistant BCR-ABL1 mutationsJing Ai, Ramon V Tiu
The Journal of Community and Supportive Oncology|April 2, 2015
Current and novel therapeutic approaches in myelodysplastic syndromesFayez Estephan, Ramon V Tiu
Translational Medicine @ Unisa|April 30, 2014
Molecular genetics of myelofibrosis and its associated disease phenotypesAli Tabarroki, Ramon V Tiu
Leukemia Research|July 19, 2011
Lenalidomide in del 5q MDS: responses and side effects revisitedRamon V Tiu, Mikkael A Sekeres
Expert Opinion on Biological Therapy|June 14, 2008
The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and myelodysplastic syndromesRamon V Tiu, Mikkael A Sekeres
Current Opinion in Hematology|January 1, 2014
Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromesRamon V Tiu, Mikkael A Sekeres
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 11, 2013
Biological rationale and clinical use of interferon in the classical BCR-ABL-negative myeloproliferative neoplasmsBrady L Stein, Ramon V Tiu
British Journal of Haematology|July 1, 2009
Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignanciesJaroslaw P Maciejewski, Ramon V Tiu, Christine O'Keefe
Expert Opinion on Investigational Drugs|May 20, 2011
Clofarabine for myelodysplastic syndromesRamon V Tiu, Fabiola Traina, Mikkael A Sekeres
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Expert Opinion on Investigational Drugs|June 7, 2012
Immunomodulatory agents in myelofibrosisAli Tabarroki, Ramon V Tiu
Therapeutic Advances in Hematology|November 1, 2014
Practical management of patients with chronic myeloid leukemia who develop tyrosine kinase inhibitor-resistant BCR-ABL1 mutationsJing Ai, Ramon V Tiu
The Journal of Community and Supportive Oncology|April 2, 2015
Current and novel therapeutic approaches in myelodysplastic syndromesFayez Estephan, Ramon V Tiu
Translational Medicine @ Unisa|April 30, 2014
Molecular genetics of myelofibrosis and its associated disease phenotypesAli Tabarroki, Ramon V Tiu
Leukemia Research|July 19, 2011
Lenalidomide in del 5q MDS: responses and side effects revisitedRamon V Tiu, Mikkael A Sekeres
Expert Opinion on Biological Therapy|June 14, 2008
The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and myelodysplastic syndromesRamon V Tiu, Mikkael A Sekeres
Current Opinion in Hematology|January 1, 2014
Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromesRamon V Tiu, Mikkael A Sekeres
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 11, 2013
Biological rationale and clinical use of interferon in the classical BCR-ABL-negative myeloproliferative neoplasmsBrady L Stein, Ramon V Tiu
British Journal of Haematology|July 1, 2009
Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignanciesJaroslaw P Maciejewski, Ramon V Tiu, Christine O'Keefe
Expert Opinion on Investigational Drugs|May 20, 2011
Clofarabine for myelodysplastic syndromesRamon V Tiu, Fabiola Traina, Mikkael A Sekeres
Pageof 9